Steve Mandel's UNH Position Overview
Steve Mandel (via Lone Pine Capital LLC) currently holds 1.69 M shares of UnitedHealth Group Incorporated (UNH) worth $0, representing 0.00% of the portfolio. First purchased in 2017-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Steve Mandel has maintained a strategic position in UNH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2017, adding 2.7 M shares. Largest reduction occurred in Q2 2020, reducing 1.59 M shares.
Analysis based on 13F filings available since 2013 Q2
Steve Mandel's UnitedHealth Group Incorporated (UNH) Holding Value Over Time
Track share changes against reported price movement
Quarterly UnitedHealth Group Incorporated (UNH) Trades by Steve Mandel
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2017 | +1.71 M | New Buy | 1.71 M | $185.42 |
| Q3 2017 | +2.7 M | Add 158.17% | 4.4 M | $195.85 |
| Q4 2017 | -761,163 | Reduce 17.29% | 3.64 M | $220.46 |
| Q1 2018 | +612,852 | Add 16.83% | 4.25 M | $214.00 |
| Q2 2018 | -133,000 | Reduce 3.13% | 4.12 M | $245.34 |
| Q3 2018 | -1.1 M | Reduce 26.78% | 3.02 M | $266.04 |
| Q4 2018 | +557,057 | Add 18.46% | 3.57 M | $249.12 |
| Q2 2019 | +197,536 | Add 5.53% | 3.77 M | $244.01 |
| Q3 2019 | +756,600 | Add 20.06% | 4.53 M | $217.32 |
| Q4 2019 | -285,800 | Reduce 6.31% | 4.24 M | $293.98 |
| Q1 2020 | +370,917 | Add 8.74% | 4.61 M | $249.38 |
| Q2 2020 | -1.59 M | Reduce 34.46% | 3.02 M | $294.95 |
| Q3 2020 | +922,392 | Add 30.50% | 3.95 M | $311.77 |
| Q4 2020 | -766,411 | Reduce 19.42% | 3.18 M | $350.68 |
| Q1 2021 | -33,446 | Reduce 1.05% | 3.15 M | $372.07 |
| Q2 2021 | -140,584 | Reduce 4.47% | 3.01 M | $400.44 |
| Q4 2021 | -709,903 | Reduce 23.62% | 2.3 M | $502.14 |
| Q1 2022 | -1.43 M | Reduce 62.30% | 865,578 | $509.97 |
| Q2 2022 | -65,266 | Reduce 7.54% | 800,312 | $513.63 |
| Q3 2022 | +139,144 | Add 17.39% | 939,456 | $505.04 |
| Q4 2022 | +124,144 | Add 13.21% | 1.06 M | $530.18 |
| Q1 2023 | -172,433 | Reduce 16.21% | 891,167 | $472.59 |
| Q1 2024 | -891,167 | Sold Out | 891,167 | $0.00 |
| Q2 2024 | +944,317 | New Buy | 944,317 | $509.26 |
| Q3 2024 | -122,437 | Reduce 12.97% | 821,880 | $584.68 |
| Q4 2024 | -821,880 | Sold Out | 821,880 | $0.00 |
| Q2 2025 | +1.69 M | New Buy | 1.69 M | $311.97 |
| Q3 2025 | -1.69 M | Sold Out | 1.69 M | $0.00 |
Steve Mandel's UnitedHealth Group Incorporated Investment FAQs
Steve Mandel first purchased UnitedHealth Group Incorporated (UNH) in Q2 2017, acquiring 1,705,353 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steve Mandel has held UnitedHealth Group Incorporated (UNH) for 34 quarters since Q2 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steve Mandel's largest addition to UnitedHealth Group Incorporated (UNH) was in Q3 2017, adding 4,402,726 shares worth $862.27 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steve Mandel's firm, Lone Pine Capital LLC, owns 1,693,347 shares of UnitedHealth Group Incorporated (UNH), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, UnitedHealth Group Incorporated (UNH) represents approximately 0.00% of Steve Mandel's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steve Mandel's peak holding in UnitedHealth Group Incorporated (UNH) was 4,613,971 shares, as reported at the end of Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.